0      0

AONN+ Annual 2020

SAT10 - Breakout Session 7 | Navigating Unknown Primary Cancer


Nov 7, 2020 2:15pm ‐ Nov 7, 2020 3:15pm


Description

The American Cancer Society estimates that between 2% and 5% of patient who have been diagnosed with metastatic cancer however the primary site can’t be located. This session will discuss how clinical decisions are made when a primary cancer site cannot be diagnosed.

Learning Objectives:
  • The learner will be able to state three reasons why a primary site can’t be located.
  • The learner will be able to state the largest pathological type of cancer from an unknown primary
  • The learner will be able to state the treatment options for cancers with an unknown primary.

Speaker(s):

  • Emma E. Furth, MD, Professor of Pathology and Laboratory Medicine, Hospital at the University of Pennsylvania

You must be logged in and own this session in order to post comments.